🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Ceftaroline fosamil is an intravenous (IV) drug that belongs to a group of ...
Status
Unknown
Location
Children's Hospital of Michigan
Start Date
2016-08
Trial ID
NCT02600793
Treatments Being Tested
To evaluate the pharmacokinetic (PK) profiles of ceftaroline and avibactam ...
Status
Completed
Location
Investigational Site
Start Date
2012-05
Trial ID
NCT01624246
Treatments Being Tested
The study will be conducted to investigate the pharmacokinetics of ceftarol...
Status
Unknown
Location
Medical University of Vienna
Start Date
2013-12
Trial ID
NCT02007122
Treatments Being Tested
The purpose of this study is to investigate the effect of administration of...
Status
Completed
Location
Research Site
Start Date
2013-08
Trial ID
NCT01789528
Quasi-experimental intervention multicenter trial of patients treated with ...
Status
Unknown
Location
Hospital de Poniente-El Ejido
Start Date
2019-07-09
Trial ID
NCT03941951
Treatments Being Tested
Ceftaroline is a piece of new cephalosporin very active on resistant staphy...
Status
Completed
Location
CHU Dijon
Start Date
2015-04-29
Trial ID
NCT02806882
Treatments Being Tested
The purpose of this study is to assess the safety, tolerability, and pharma...
Status
Completed
Location
Research site
Start Date
2012-04
Trial ID
NCT01577589
This is a single dose study in healthy male volunteers to investigate the e...
Status
Completed
Location
Research Site
Start Date
2011-02
Trial ID
NCT01290900
Treatments Being Tested
Dosing of ceftaroline in patients with chronic kidney disease is defined, b...
Status
Completed
Location
University of Maryland Medical Center
Start Date
2018-03-09
Trial ID
NCT04152694
Treatments Being Tested
Gram-positive cocci, particularly Staphylococcus aureus and coagulase-negat...
Status
Active Not Recruiting
Location
Nîmes University Hospital
Start Date
2024-01-01
Trial ID
NCT06688084
Treatments Being Tested